| Bioactivity | Urumin has antiviral activity against the human influenza A virus. Urumin inhibits the growth of PR8 influenza virus (IC50: 3.8 μM). Urumin targets the conserved stalk of H1 hemagglutini, and is effective at neutralizing drug-resistant H1 influenza viruses. Urumin protects naive mice from lethal influenza infection[1]. |
| Name | Urumin |
| CAS | 2215863-74-2 |
| Sequence | Ile-Pro-Leu-Arg-Gly-Ala-Phe-Ile-Asn-Gly-Arg-Trp-Asp-Ser-Gln-Cys-His-Arg-Phe-Ser-Asn-Gly-Ala-Ile-Ala-Cys-Ala |
| Shortening | IPLRGAFINGRWDSQCHRFSNGAIACA |
| Formula | C129H198N42O35S2 |
| Molar Mass | 2961.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Holthausen DJ, et al. An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses. Immunity. 2017 Apr 18;46(4):587-595. |
Urumin
CAS: 2215863-74-2 F: C129H198N42O35S2 W: 2961.34
Urumin has antiviral activity against the human influenza A virus. Urumin inhibits the growth of PR8 influenza virus (IC
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.